Literature DB >> 3576677

Clinically important interaction of cyclosporine and erythromycin.

B M Murray, L Edwards, G D Morse, R R Kohli, R C Venuto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3576677     DOI： 10.1097/00007890-198704000-00037

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  8 in total

Review 1.  Pharmacokinetic drug interactions with cyclosporin (Part II).

Authors:  G C Yee; T R McGuire
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 2.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

Review 3.  Primary care of the renal transplant patient.

Authors:  J D Pirsch; R Friedman
Journal:  J Gen Intern Med       Date:  1994-01       Impact factor: 5.128

4.  Effect of ponsinomycin on cyclosporin pharmacokinetics.

Authors:  W Couet; B Istin; P Seniuta; D Morel; L Potaux; J B Fourtillan
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  Lack of effect of spiramycin on cyclosporin pharmacokinetics.

Authors:  L Vernillet; P Bertault-Peres; Y Berland; J Barradas; A Durand; M Olmer
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

Review 6.  Macrolide antibacterials. Drug interactions of clinical significance.

Authors:  N A von Rosensteil; D Adam
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

7.  Giant gastric ulcers and risk factors for gastroduodenal mucosal disease in orthotopic lung transplant patients.

Authors:  D A Lipson; J A Berlin; H I Palevsky; R M Kotloff; G Tino; J Bavaria; L Kaiser; W B Long; D C Metz; G R Lichtenstein
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

Review 8.  Clinical pharmacokinetics in organ transplant patients.

Authors:  R Venkataramanan; K Habucky; G J Burckart; R J Ptachcinski
Journal:  Clin Pharmacokinet       Date:  1989-03       Impact factor: 6.447
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.